Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Smoking is the first cause of morbidity and death in psychiatric settings

Alain Braillon
CMAJ December 11, 2017 189 (49) E1534; DOI: https://doi.org/10.1503/cmaj.733483
Alain Braillon
Senior consultant, Centre Hospitalier Universitaire d’Amiens, Amiens, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Gatov and colleagues’ concern for the dramatic premature death of patients with schizophrenia “8 years younger than those without schizophrenia” was a missed opportunity to call a spade a spade.1

The issue is not new: adults with schizophrenia are 3.5 times more likely to die than the general population, mainly because of lung cancer, and chronic obstructive pulmonary and cardiovascular diseases; standardized mortality ratios are 52/100 000 person-years for suicide versus 75 for lung cancer in this group.2

Knudsen’s enduring crusade against smoking showed sad evidence that the problem remains unchanged.3

Why are specific benefits of smoking cessation in the psychiatric setting almost ignored? In a randomized controlled trial, nicotine replacement therapy prevented agitation and neuroleptics use in smokers with schizophrenia admitted to the emergency department.4 Whatever immediate effects smoking may have on perceived stress (decreasing pain caused by withdrawal syndrome), overall smoking generates or aggravates negative emotional states.5 A time-series analysis showed that smoke-free policy reduced the incidence of physical assaults in psychiatric settings.6 Robust evidence has been available since 2004 showing that tobacco cessation treatment improves other outcomes for substance use (alcohol and illicit drugs) and predicts more favourable long-term outcomes.3 Last, treatments are safe and effective.7

However, it is most depressing that a recent article called for “resources” in implementing smoke-free policies and concluded that “research into the effect of smoking cessation on mental illnesses should also be a priority.”8

Footnotes

  • Competing interests: None declared.

References

  1. ↵
    1. Gatov E,
    2. Rosella L,
    3. Chiu M,
    4. et al
    . Trends in standardized mortality among individuals with schizophrenia, 1993–2012: a population-based, repeated cross-sectional study. CMAJ 2017;189:E1177–87.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Olfson M,
    2. Gerhard T,
    3. Huang C,
    4. et al
    . Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 2015;72:1172–81.
    OpenUrl
  3. ↵
    1. Knudsen HK
    . Implementation of smoking cessation treatment in substance use disorder treatment settings: a review. Am J Drug Alcohol Abuse 2017;43:215–25.
    OpenUrl
  4. ↵
    1. Allen MH,
    2. Debanné M,
    3. Lazignac C,
    4. et al
    . Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 2011;168:395–9.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Hajek P,
    2. Taylor T,
    3. McRobbie H
    . The effect of stopping smoking on perceived stress levels. Addiction 2010;105:1466–71.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Robson D,
    2. Spaducci G,
    3. McNeill A,
    4. et al
    . Effect of implementation of a smoke-free policy on physical violence in a psychiatric inpatient setting: an interrupted time series analysis. Lancet Psychiatry 2017;4:540–6.
    OpenUrl
  7. ↵
    1. Anthenelli RM,
    2. Benowitz NL,
    3. West R,
    4. et al
    . Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 2016;387:2507–20.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Gage SH,
    2. Maynard OM
    . Smoke-free policies in psychiatric hospitals need resources. Lancet Psychiatry 2017;4:509–10.
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 189 (49)
CMAJ
Vol. 189, Issue 49
11 Dec 2017
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Smoking is the first cause of morbidity and death in psychiatric settings
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Smoking is the first cause of morbidity and death in psychiatric settings
Alain Braillon
CMAJ Dec 2017, 189 (49) E1534; DOI: 10.1503/cmaj.733483

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Smoking is the first cause of morbidity and death in psychiatric settings
Alain Braillon
CMAJ Dec 2017, 189 (49) E1534; DOI: 10.1503/cmaj.733483
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Trends in standardized mortality among individuals with schizophrenia, 1993–2012: a population-based, repeated cross-sectional study
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Coexisting failures do not diminish the stature of a giant
  • Dare we hope
  • Highlighting obesity as a risk factor for endometrial cancer
Show more Letters

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire